Agenparl

cancer

Agenparl English Educazione Salute Scienza e Tecnologia Social Network

THREE NEW TRANS-ATLANTIC RESEARCH TEAMS TO STUDY HARD-TO-TREAT CHILDHOOD CANCERS

Redazione
(AGENPARL) – WORCESTER (MASSACHUSETTS), lun 19 ottobre 2020 (Stand Up To Cancer) While incredible progress has been made in advancing pediatric cancer research, critical unmet needs still exist. The Stand Up To Cancer-Cancer Research UK Pediatric Cancer New Discoveries Challenge has awarded three new teams of scientists in both the......
Agenparl English Educazione Salute Scienza e Tecnologia Social Network

FOR ESOPHAGEAL CANCER, IMMUNOTHERAPY LIKELY TO PLAY LARGER ROLE

Redazione
(AGENPARL) – BETHESDA (MARYLAND), lun 19 ottobre 2020 October 19, 2020, by NCI Staff An esophagram using barium contrast shows the esophagus. Credit: iStock Immunotherapy may become part of early treatment for some people with advanced esophageal cancer, based on results from two large clinical trials. In both trials, treatment......
Agenparl English Salute Social Network

AL-JOUF HEALTH AFFAIRS HOLDS A 3-DAY HEALTH FESTIVAL OF BREAST CANCER EARLY DETECTION

Redazione
(AGENPARL) – RIYADH (KINGDOM OF SAUDI ARABIA), lun 19 ottobre 2020 ​Al-Jouf Health Affairs has held a 3-day health festival under the title: «The Pink Way» at Al-Nikhil Park in Sakaka. The festival come as part of the Affairs’ health awareness efforts in October to urge women for breast cancer......
Agenparl English Diritto & Giustizia Salute Social Network

HUMAN MEDICINES EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR): LIBTAYO, CEMIPLIMAB, CARCINOMA, SQUAMOUS CELL, DATE OF AUTHORISATION: 28/06/2019, REVISION: 4, STATUS: AUTHORISED

Redazione
(AGENPARL) – LONDON (UNITED KINGDOM), lun 19 ottobre 2020 Libtayo is a cancer medicine used on its own to treat adults with a type of skin cancer called cutaneous squamous cell carcinoma when the cancer is locally advanced (has spread nearby) or metastatic (has spread to other parts of the......
Agenparl English Diritto & Giustizia Salute Social Network

HUMAN MEDICINES EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR): TECENTRIQ, ATEZOLIZUMAB, CARCINOMA, TRANSITIONAL CELL,CARCINOMA, NON-SMALL-CELL LUNG, DATE OF AUTHORISATION: 20/09/2017, REVISION: 11, STATUS: AUTHORISED

Redazione
(AGENPARL) – LONDON (UNITED KINGDOM), lun 19 ottobre 2020 Urothelial cancer Tecentriq reduces tumours in patients with urothelial cancer that is advanced or has spread. In a study of 429 patients, the cancer shrank or was eliminated after Tecentriq treatment in 23% of patients who were not eligible for platinum......
Agenparl English Difesa Social Network

PHYSICAL TRAINERS TAKE ON BURPEE CHALLENGE FOR CANCER CHARITY

Redazione
(AGENPARL) – AUSTRALIA, dom 18 ottobre 2020 HMAS Kuttabul Physical Training Instructors have agreed to undergo some short term pain for longer term gain in a burpee challenge to aid the Sydney Breast Cancer Foundation. As part of the Foundation’s burpee fitness challenge, the Physical Training Instructors (PTI) will have to do......
Agenparl English Educazione Salute Scienza e Tecnologia Social Network

$9.1 MILLION NCI GRANT RENEWAL WILL SUPPORT CANCER RETROVIRUS RESEARCH

Redazione
(AGENPARL) – WORCESTER (MASSACHUSETTS), sab 03 ottobre 2020 (Ohio State University Wexner Medical Center) The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James) and The Ohio State University College of Veterinary Medicine (CVM) have been awarded a......
Agenparl English Educazione Salute Scienza e Tecnologia Social Network

TUMOR PROGRESSION DEPENDS ON THE TUMOR MICROENVIRONMENT

Redazione
(AGENPARL) – WORCESTER (MASSACHUSETTS), ven 02 ottobre 2020 (Tokyo Medical and Dental University) Researchers from Tokyo Medical and Dental University (TMDU) and Niigata University identified a novel mechanism by which tumors progress. By studying the role of TNF-α and TGF-β in the formation of cancer-associated fibroblasts (CAFs), the researchers found......
Agenparl English Diritto & Giustizia Salute Social Network

EMA REMINDS PHYSICIANS TO USE TECENTRIQ WITH NAB-PACLITAXEL FOR TREATING BREAST CANCER, , 01/10/2020

Redazione
(AGENPARL) – LONDON (UNITED KINGDOM), ven 02 ottobre 2020 EMA is reminding physicians to use Tecentriq (atezolizumab) only in combination with nab-paclitaxel and not with conventional paclitaxel when treating patients with locally advanced or metastatic triple-negative breast cancer that cannot be surgically removed. EMA’s advice follows the release of results......
Agenparl English Difesa Politica Estera Social Network

NORFOLK NAVAL SHIPYARD CELEBRATES BREAST CANCER AWARENESS MONTH, REMEMBERS ONE OF OUR OWN

Redazione
(AGENPARL) – WASHINGTON (DC), ven 02 ottobre 2020 NORFOLK NAVAL SHIPYARD, Portsmouth, Va. — Every October, Norfolk Naval Shipyard (NNSY) joins the nation in celebrating Breast Cancer Awareness Month – a month dedicated to bringing awareness to a disease that has rocked the core of both women and men alike. ......

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More